Exclusion Criteria:~* The subject has any significant change in his/her medical condition since participation
in Study M15-566 (NCT02880956) that could interfere with the subject's participation in Study M15-570, could
place the subject at increased risk, or could confound interpretation of study results~* More than 8 weeks have
elapsed since the subject received his/her last dose of study drug in Study M15-566 (NCT02880956)~* The subject
is concurrently enrolled in another interventional clinical study involving a therapeutic agent with the
exception of Study M15-566 (NCT02880956)
